Countdown to 2021 CBIIC：
Chief Scientist (Pharmacology and Toxicology) of Center for Drug Evaluation, CFDA
Dr. Xu is currently working in the Center for Drug Evaluation (CDE), Chinese Food and Drug Administration (CFDA), as the chief scientist in pharmacology and toxicology. Prior to this appointment, he worked as a senior Pharmacologist/Toxicologist in the Office of New Drugs (OND) at US Food and Drug Administration, Center for Drug Evaluation and Research (US FDA/CDER). Before joining FDA, he worked as a senior scientist in pharmacogenomics and toxicogenomics in Gene Logic Ltd. Dr. Xu received a Master degree in pathology and PhD degree in pharmacology and toxicology from the University of Arkansas for Medical Sciences. He completed his PhD research project in Duke University and had his postdoctoral training in the National Center for Toxicological Research (NCTR). Dr. Xu has over 20-year experience in Toxicology and over 12-year in drug regulation. He is a Diplomate of American Board of Toxicology (DABT) since 2005. He is a full member of Society of Toxicology (SOT) and the immediate past president of the American Association of Chinese in Toxicology (AACT).